Authors:
Low, CMR
Black, JW
Broughton, HB
Buck, IM
Davies, JMR
Dunstone, DJ
Hull, RAD
Kalindjian, SB
McDonald, IM
Pether, MJ
Shankley, NP
Steel, KIM
Citation: Cmr. Low et al., Development of peptide 3D structure mimetics: Rational design of novel peptoid cholecystokinin receptor antagonists, J MED CHEM, 43(19), 2000, pp. 3505-3517
Authors:
McDonald, IM
Dunstone, DJ
Kalindjian, SB
Linney, ID
Low, CMR
Pether, MJ
Steel, KIM
Tozer, MJ
Vinter, JG
Citation: Im. Mcdonald et al., 2,7-dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a new template for the design of CCK2 receptor antagonists, J MED CHEM, 43(19), 2000, pp. 3518-3529
Authors:
Linney, ID
Buck, IM
Harper, EA
Kalindjian, SB
Pether, MJ
Shankley, NP
Watt, GF
Wright, PT
Citation: Id. Linney et al., Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H-3 receptor antagonists, J MED CHEM, 43(12), 2000, pp. 2362-2370
Authors:
Tozer, MJ
Buck, IM
Cooke, T
Kalindjian, SB
McDonald, IM
Pether, MJ
Steel, KIM
Citation: Mj. Tozer et al., 4-chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: The design of potent histamine H-3 receptor antagonists, BIOORG MED, 9(21), 1999, pp. 3103-3108
Citation: Mj. Tozer et al., From histamine to imidazolylalkyl-sulfonamides: the design of a novel series of histamine H-3-receptor antagonists (vol 9, pg 1825, 1999), BIOORG MED, 9(20), 1999, pp. 3061-3061
Citation: Mj. Tozer et al., From histamine to imidazolylalkyl-sulfonamides: The design of a novel series of histamine H-3-receptor antagonists., BIOORG MED, 9(13), 1999, pp. 1825-1830